Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Ophthalmodynamometry”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 559 records · Page 31Linked to original sources
PubMed1976

[Changes in several hemodynamic indices in cerebral arachnoiditis[].

The author examined 195 patients from 17 to 60 years with cerebral arachnoiditis. The following haemodynamical factors were analyzed: rheoencephalograms, synchronous rigistration of the REG and EEG, peripheral and retinal pressures. The studies showed tow tendencies of the haemodynamic changes: regional hypertonicity and hypotonicity. The specificity of the haemodynamic factors depends on the phase of the hypertensive syndrome and the duration of the disease.

Adolescent↗
PubMedDate not supplied

[The functional effect of internal carotid TEA on ocular hemodynamics].

Fifteen patients with a stenosis of the internal carotid artery superior than a 70% were studied in order to analyze the effects of TEA on the ocular hemodynamics. Analysis was made by ophthalmodynamography and electrofunctional studies. An improvement of the ocular hemodynamics was found, particularly by ophthalmodynamography and visual evoked potentials.

Aged↗
PubMed1992

[Early postoperative corneal astigmatism. Comparison of various suture techniques].

We compared two suture techniques after phacoemulsification and implantation of a standard PMMA posterior chamber lens with a 7 mm intrascleral lamellar incision: the cross-stitch (double running) suture closure and the one-stitch technique. Two series with 100 patients each were examined. In the early postoperative period the astigmatism induced was 1.9 +/- 1.4 D in the cross-stitch group and 1.5 +/- 1.0 in the one-stitch group (P = 0.01). In the latter group, 20% more of the patients were found to have a moderate amount of astigmatism. Four weeks after surgery, however, there were no differences between the two groups. The induced astigmatism in both groups was 1.0 D.

Astigmatism↗
PubMedDate not supplied

Pentoxifylline (PTX)--an alternative treatment in Graves' ophthalmopathy (inactive phase): assessment by a disease specific quality of life questionnaire and by exophthalmometry in a prospective randomized trial.

PURPOSE: To investigate the effect of pentoxifylline (PTX) in subjects with inactive Graves' ophthalmopathy (GO) through a specific quality of life (QOL) questionnaire and exophthalmometry readings. METHODS: Eighteen females were randomly divided in two groups. Group A (n=9) was treated with PTX 1200 mg orally/day for 6 months. Group B (n=9) received placebo during the initial 6 months and then PTX for another 6 months. Proptosis measurements were carried out every 3 months and a questionnaire graded from 0 to 10 according to the severity of the symptoms was performed at baseline and after placebo and PTX administration. RESULTS: At baseline, Group A questionnaire score values were 5.5 (median; range 3.5 to 8.0), and 5.0 after 6 months (3.0 to 6.0; p=0.01). In Group B, baseline values were not significantly different after 6 months of placebo: 6.0 (4.5 to 7.0) and 5.5 (4.5 to 7.0), respectively. However, a significant change was observed 6 months after PTX: 4.0 (2.0 to 5.0; p<0.001). Patients in Group A had a progressive improvement of proptosis during PTX: at baseline, 23 mm (median; range 20 to 32); after 3 months, 23 mm (18 to 30; p=0.02); and after 6 months, 23 mm (18 to 30; p=0.005). In Group B, proptosis remained stable during placebo: at baseline, 23 mm (21 to 25); after 3 months, 23 mm (20 to 25); and after 6 months, 23.5 mm (20 to 25). A significant change was observed after 3 and 6 months of PTX: 22 mm (19 to 24; p=0.0006) and 20.8 mm (17 to 25; p=0.0003), respectively. CONCLUSIONS: Pentoxifylline seems to improve the QOL of patients in the inactive phase of GO. The objective findings of the proptosis readings corroborate to suggest that PTX may be an effective and promising drug in the inactive phase of GO.

Adult↗
PubMed1992

Retinal vein occlusion.

Retinal vein occlusion is a common form of retinal vascular disease, especially in middle-aged and older individuals. The diagnosis is based on the funduscopic finding of retinal vein dilatation in association with retinal hemorrhages and cotton-wool spots. The pathology can involve the entire venous system or can be limited to a branch of the central retinal vein. Retinal vein occlusion can be distinguished clinically from diabetic retinopathy and other retinal diseases. Treatment for the acute phase of retinal vein occlusion has been disappointing. However, some late complications, such as persistent macular edema and neovascularization of the iris and retina, respond well to retinal photocoagulation. The family physician has an important role in detecting and controlling risk factors for retinal vein occlusion, including hypertension, diabetes mellitus and hyperviscosity syndromes.

Adult↗